Frazier Life Sciences Management’s Merus MRUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-373,100
| Closed | -$15.7M | – | 52 |
|
2025
Q1 | $15.7M | Hold |
373,100
| – | – | 0.72% | 27 |
|
2024
Q4 | $15.7M | Hold |
373,100
| – | – | 0.65% | 30 |
|
2024
Q3 | $18.6M | Hold |
373,100
| – | – | 0.75% | 30 |
|
2024
Q2 | $22.1M | Sell |
373,100
-373,379
| -50% | -$22.1M | 1.03% | 25 |
|
2024
Q1 | $33.6M | Hold |
746,479
| – | – | 1.42% | 23 |
|
2023
Q4 | $20.5M | Hold |
746,479
| – | – | 1.1% | 25 |
|
2023
Q3 | $17.6M | Hold |
746,479
| – | – | 1.17% | 20 |
|
2023
Q2 | $19.7M | Hold |
746,479
| – | – | 1.17% | 21 |
|
2023
Q1 | $13.7M | Hold |
746,479
| – | – | 0.99% | 25 |
|
2022
Q4 | $11.5M | Hold |
746,479
| – | – | 0.72% | 27 |
|
2022
Q3 | $15M | Buy |
746,479
+72,500
| +11% | +$1.45M | 1.15% | 21 |
|
2022
Q2 | $15.3M | Buy |
673,979
+45,000
| +7% | +$1.02M | 1.44% | 19 |
|
2022
Q1 | $16.6M | Buy |
+628,979
| New | +$16.6M | 1.42% | 23 |
|